Journal of Hepatocellular Carcinoma
Volume 10, 2023 - Issue
Open access
206
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience
Xian Pan1 Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, People’s Republic of China;2 Department of Interventional Radiology, Fujian Provincial Hospital, Fuzhou, People’s Republic of ChinaView further author information
, Shao-Jie Wu1 Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, People’s Republic of China;2 Department of Interventional Radiology, Fujian Provincial Hospital, Fuzhou, People’s Republic of ChinaView further author information
, Yi Tang1 Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, People’s Republic of China;2 Department of Interventional Radiology, Fujian Provincial Hospital, Fuzhou, People’s Republic of ChinaView further author information
, Yan-Feng Zhou1 Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, People’s Republic of China;2 Department of Interventional Radiology, Fujian Provincial Hospital, Fuzhou, People’s Republic of ChinaView further author information
, Jie-Wei Luo1 Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, People’s Republic of China;3 Department of Traditional Chinese Medicine, Fujian Provincial Hospital, Fuzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
& View further author information
Zhu-Ting Fang1 Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, People’s Republic of China;2 Department of Interventional Radiology, Fujian Provincial Hospital, Fuzhou, People’s Republic of ChinaView further author information
Pages 883-892
|
Received 12 Jan 2023, Accepted 30 May 2023, Published online: 09 Jun 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.